Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysis

  • Chenjing Zhu
    State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China
  • Xuelei Ma
    State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China
  • Yuanyuan Hu
    West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, PR China
  • Linghong Guo
    West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, PR China
  • Bo Chen
    Department of Oncology, The First People's Hospital of Chengdu City, Chengdu 610041, PR China
  • Kai Shen
    State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China
  • Yue Xiao
    West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, PR China

書誌事項

公開日
2016-06-14
DOI
  • 10.18632/oncotarget.10019
公開者
Impact Journals, LLC

収録刊行物

  • Oncotarget

    Oncotarget 7 (28), 44545-44557, 2016-06-14

    Impact Journals, LLC

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ